N
Neil Woodford
Researcher at Health Protection Agency
Publications - 128
Citations - 11151
Neil Woodford is an academic researcher from Health Protection Agency. The author has contributed to research in topics: Klebsiella pneumoniae & Antibacterial agent. The author has an hindex of 59, co-authored 128 publications receiving 10373 citations. Previous affiliations of Neil Woodford include Queen Mary University of London & Public Health England.
Papers
More filters
Journal ArticleDOI
Multiplex PCR for rapid detection of genes encoding acquired metallo-beta-lactamases.
Journal ArticleDOI
Infections caused by Gram-positive bacteria: a review of the global challenge
Neil Woodford,David M. Livermore +1 more
TL;DR: Using combinations of molecular epidemiological tools, which characterize the resistant isolates and their resistance determinants, scientists can track highly successful bacterial strains at local, national, and international levels, and these methods have provided new insights into the evolution of key pathogens, and this information may aid the design of control strategies and vaccines.
Journal ArticleDOI
Editorial: Assessing the antimicrobial susceptibility of bacteria obtained from animals
Stefan Schwarz,Peter Silley,Shabbir Simjee,Neil Woodford,Engeline van Duijkeren,Alan P. Johnson,Wim Gaastra +6 more
TL;DR: A review of the published literature revealed a number of recurring errors with regard to methodology, quality control, appropriate interpretive criteria, and calculation of MIC(50) and MIC(90) values.
Journal ArticleDOI
Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains
Olivier Clermont,Hiran Dhanji,Mathew Upton,Tarek M. Gibreel,Andrew J. Fox,David A. Boyd,Michael R. Mulvey,Patrice Nordmann,Etienne Ruppé,J. L. Sarthou,Thierry Frank,Thierry Frank,Sophie Vimont,Guillaume Arlet,Catherine Branger,Neil Woodford,Erick Denamur +16 more
TL;DR: A PCR-based assay is developed that easily identifies a clone with high likelihood of producing ESBLs, including CTX-M-15, which represents 3% of non-ESBL B2 isolates originating from urinary tract infections in Paris.
Journal ArticleDOI
Identification and screening of carbapenemase-producing Enterobacteriaceae
Patrice Nordmann,Marek Gniadkowski,Christian G. Giske,Laurent Poirel,Neil Woodford,Vivi Miriagou +5 more
TL;DR: Phenotypic and molecular-based techniques are able to identify these carbapenemase producers, although with variable efficiencies, and the detection of carriers still relies mostly on the use of screening culture media.